Electrical Stimulation of Human Myocytes in Microgravity
NCT03665051 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2025-06-11
Summary
The purpose of this study is to evaluate the changes of muscle, in microgravity. Which will help explain the health benefits of exercise. There are tests that can be done to tell researchers more about the human body, such as a dual energy x-ray absorptiometry (DEXA) scan, which measures body composition (fat and lean body mass). The use of muscle testing and a Handgrip test can tell us about the strength and power within an individual's muscles. A VO2 max test helps us understand the aerobic fitness level of an individual and one of the most important aspects of this study are muscle cells. A muscle biopsy allows us to obtain muscle cells from the thigh, which will be sent into space by a rocket. Researchers will study these muscle cells in a low gravity environment aboard the International Space Station. Studying the muscle cells under those conditions will potentially mimic an accelerated aging process, which will help researchers better understand muscle wasting in the elderly.
Conditions
Interventions
- PROCEDURE
-
Muscle Tissue Biopsy
A biopsy of the Vastus Lateralis muscle will be performed on the left leg using the Bergstrom technique.The skin will be incised (approximately 0.75 cm) with a #11 scalpel, and the Bergstrom needle will be inserted into the Vastus Lateralis. Approximately 150 mg of muscle tissue will be obtained under suction. After the biopsy, pressure will be applied to stop bleeding and the skin will be closed with Steri strips (suture(s) if allergy to steri strips and removal 7-10 days post biopsy). A sterile dressing will be applied. Ace bandage may also be used along with applied pressure and an ice pack for any swelling and pain relief.
- OTHER
-
Maximal Oxygen Consumption (V02max)
Aerobic fitness will be determined by measuring maximal O2 consumption (VO2max) during a stationary bicycle exercise test. Heart rate, blood pressure and ECG will be recorded throughout this test. Subjects will breathe through a low resistance mouthpiece and wear a nose clip. Expired gases will be measured by indirect calorimetry and heart rate monitored by a portable heart rate monitor. Following a standardized warm up, subjects will begin exercising at a moderate intensity with the workload increased every minute until the subject can no longer continue. A leveling-off (plateau) or decline in oxygen uptake should be demonstrated in order to be reasonably sure that a subject has achieved the maximum capacity for aerobic metabolism.
Sponsors & Collaborators
-
AdventHealth Translational Research Institute
lead OTHER
Principal Investigators
-
Paul Coen, PhD · Study Principal Investigator
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-01-25
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers
NCT01962454 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Energy Metabolism in Metabolic Myopathies
NCT07268287 ·Status: COMPLETED ·Phase: NA
-
Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies
NCT06532474 ·Status: RECRUITING
-
Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography
NCT03490214 ·Status: COMPLETED ·Phase: NA
-
Twice Weekly Steroids and Exercise as Therapy for DMD
NCT04322357 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005)
NCT00529659 ·Status: COMPLETED ·Phase: PHASE2
-
Microdystrophin Gene Transfer Study in Adolescents and Children With DMD
NCT03368742 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Finding the Optimum Regimen for Duchenne Muscular Dystrophy
NCT01603407 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of a Mechanical Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders
NCT00839033 ·Status: TERMINATED ·Phase: PHASE3
-
Non-Invasive Assessment of Skeletal Muscle Loss in Cancer Patients - Phase II
NCT01694602 ·Status: COMPLETED
-
Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1
NCT02122952 ·Status: COMPLETED ·Phase: PHASE1
-
Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy
NCT01645098 ·Status: COMPLETED ·Phase: NA
-
Clinical Intramuscular Gene Transfer Trial of rAAVrh74.MCK.Micro-Dystrophin to Patients With Duchenne Muscular Dystrophy
NCT02376816 ·Status: COMPLETED ·Phase: PHASE1
-
Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy
NCT00004646 ·Status: COMPLETED ·Phase: PHASE3
-
Multispectral Optoacoustic Tomography for Advanced Imaging of Centronuclear Myopathy
NCT07021820 ·Status: RECRUITING
-
Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy
NCT03333590 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Aerobic Training in Patients With Congenital Myopathies
NCT02020187 ·Status: COMPLETED ·Phase: NA
-
Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
NCT05747924 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pre-Symptomatic Study of Intravenous Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2
NCT03505099 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy
NCT05429372 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of the Effect of BIIB023 on Muscle Atrophy in Healthy Male Volunteers
NCT01943513 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating Muscle Weakness Improvement With Lorcaserin in ICU
NCT02523690 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Effect and Safety MABs Administration m.3243A>G Mutation Carriers
NCT05962333 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy
NCT06280209 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2
NCT02704325 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2